- Home
- LRHC vs SNGX Comparison
LRHC vs SNGX Comparison
Compare LRHC & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LRHC
- SNGX
- Stock Information
- Founded
- LRHC 2004
- SNGX 1987
- Country
- LRHC United States
- SNGX United States
- Employees
- LRHC N/A
- SNGX N/A
- Industry
- LRHC
- SNGX Biotechnology: Pharmaceutical Preparations
- Sector
- LRHC
- SNGX Health Care
- Exchange
- LRHC Nasdaq
- SNGX Nasdaq
- Market Cap
- LRHC 6.7M
- SNGX 6.5M
- IPO Year
- LRHC 2023
- SNGX 1987
- Fundamental
- Price
- LRHC $0.15
- SNGX $2.16
- Analyst Decision
- LRHC
- SNGX
- Analyst Count
- LRHC 0
- SNGX 0
- Target Price
- LRHC N/A
- SNGX N/A
- AVG Volume (30 Days)
- LRHC 20.2M
- SNGX 199.2K
- Earning Date
- LRHC 04-15-2025
- SNGX 05-09-2025
- Dividend Yield
- LRHC N/A
- SNGX N/A
- EPS Growth
- LRHC N/A
- SNGX N/A
- EPS
- LRHC N/A
- SNGX N/A
- Revenue
- LRHC $69,448,786.00
- SNGX $119,371.00
- Revenue This Year
- LRHC N/A
- SNGX N/A
- Revenue Next Year
- LRHC N/A
- SNGX N/A
- P/E Ratio
- LRHC N/A
- SNGX N/A
- Revenue Growth
- LRHC 118.67
- SNGX N/A
- 52 Week Low
- LRHC $0.09
- SNGX $1.68
- 52 Week High
- LRHC $3.36
- SNGX $14.83
- Technical
- Relative Strength Index (RSI)
- LRHC 42.67
- SNGX 51.88
- Support Level
- LRHC $0.09
- SNGX $1.97
- Resistance Level
- LRHC $0.22
- SNGX $2.23
- Average True Range (ATR)
- LRHC 0.03
- SNGX 0.17
- MACD
- LRHC -0.00
- SNGX 0.02
- Stochastic Oscillator
- LRHC 46.29
- SNGX 86.36
About LRHC La Rosa Holdings Corp.
La Rosa Holdings Corp operates in the U.S. residential real estate market. It is a holding company for agent-centric, technology-integrated, cloud-based, multi-service real estate companies. The company's business is organized based on the services it provides internally to the agents and to the public, which are residential and commercial real estate brokerage, franchising, real estate brokerage education and coaching, and property management. The company has five reportable segments namely: Real Estate Brokerage Services (Residential), Franchising Services, Coaching Services, Property Management and Real Estate Brokerage Services (Commercial). It derives maximum revenue from Real Estate Brokerage Services (Residential) segment.
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).